Results 11 to 20 of about 1,704,178 (384)

Inflammation to Pulmonary Diseases [PDF]

open access: yesMediators of Inflammation, 2016
Inflammation, which is induced and perpetuated by microorganism pathogens or from the damage or death of host cells, is an essential component of various common respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, and acute respiratory distress syndrome (ARDS), as well as of less common ones, for example ...
Kang-Yun Lee   +2 more
openaire   +4 more sources

Arginase and pulmonary diseases [PDF]

open access: yesNaunyn-Schmiedeberg's Archives of Pharmacology, 2008
Recent studies have indicated that arginase, which converts L-arginine into L-ornithine and urea, may play an important role in the pathogenesis of various pulmonary disorders. In asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, increased arginase activity in the airways may contribute to obstruction and hyperresponsiveness of ...
Harm Maarsingh, Tonio Pera, Herman Meurs
openaire   +4 more sources

COgnitive-Pulmonary Disease [PDF]

open access: yesBioMed Research International, 2014
Over the past few decades, chronic obstructive lung disease (COPD) has been considered a disease of the lungs, often caused by smoking. Nowadays, COPD is regarded as a systemic disease. Both physical effects and effects on brains, including impaired psychological and cognitive functioning, have been demonstrated.
Rudolf W. H. M. Ponds   +4 more
openaire   +4 more sources

Autophagy and pulmonary disease [PDF]

open access: yesTherapeutic Advances in Respiratory Disease, 2019
Autophagy is a process of cell self-renewal that is dependent on the degradation of the cytoplasmic proteins or organelles of lysosomes. Many diseases, such as metabolic diseases, cancer, neurodegenerative diseases, and lung diseases, have been confirmed to be associated with elevated or impaired levels of autophagy.
Shi-xia Liao   +5 more
openaire   +4 more sources

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?

open access: yesEuropean Respiratory Review, 2020
Despite the advent of new therapies and improved outcomes in patients with pulmonary arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis remains unchanged.
Robert A. Lewis   +3 more
doaj   +1 more source

Bilateral diaphragmatic paralysis after kidney surgery

open access: yesMonaldi Archives for Chest Disease, 2015
A 57-year-old woman underwent an enucleoresection of her right kidney angiomyolipoma. Two weeks later she was admitted to our hospital because of dyspnea at rest with orthopnea.
S. Sozzo   +6 more
doaj   +1 more source

Temporal Trends in Diagnostic Hemodynamics and Survival of Patients with Pulmonary Hypertension: A Single-Center Study

open access: yesLife, 2023
Advances in the diagnosis and treatment of pulmonary hypertension (PH) have gradually improved the disease course. This retrospective cohort study aims to explore the diagnostic hemodynamic profile and survival of PH patients and their temporal changes ...
Georgios E. Papadopoulos   +12 more
doaj   +1 more source

Pulmonary Diseases and Corticosteroids [PDF]

open access: yesThe Indian Journal of Pediatrics, 2008
Steroids (corticosteroids) are anti-inflammatory drugs. Corticosteroids are used in many pulmonary conditions. Corticosteroids have a proven beneficial role in asthma, croup (Laryngotracheobronchitis), decreasing the risk and severity of respiratory distress syndrome (RDS), allergic bronchopulmonary aspergillosis, interstitial lung disease, hemangioma ...
Gulshan Rai Sethi, Kamal Kumar Singhal
openaire   +3 more sources

Under pressure: pulmonary hypertension associated with left heart disease. [PDF]

open access: yes, 2015
© ERS 2015.Pulmonary hypertension (PH) associated with left heart disease (PH-LHD) is the most common type of PH, but its natural history is not well understood.
Farber, HW, Gibbs, S
core   +6 more sources

Parameter inference in a computational model of hemodynamics in pulmonary hypertension [PDF]

open access: yes, 2021
Pulmonary hypertension (PH), defined by a mean pulmonary arterial pressure (mPAP) $>$ 20 mmHg, is characterized by increased pulmonary vascular resistance and decreased pulmonary arterial compliance. There are few measurable biomarkers of PH progression, but a conclusive diagnosis of the disease requires invasive right heart catheterization (RHC ...
arxiv   +1 more source

Home - About - Disclaimer - Privacy